Monday, June 29, 2026

New Obesity Drug Shows Big Promise — and It’s Not from Eli Lilly or Novo

Metsera leads emerging obesity treatments with promising drug MET-233i, showing significant weight loss in trials, amid rising competition.

Is South Korea’s Military Intelligence Overstepping? Investigating the North Korean Drone Controversy

Defense Minister Ahn Gyu-back calls for an investigation into civilian drone incursions into North Korea and emphasizes intelligence reforms.

Orthognathic Surgery: More Than Cosmetic, It’s About Restoring Oral Function

Orthognathic surgery corrects jaw alignment for better function and aesthetics, requiring careful diagnosis and post-operative care.

Discover the Future of Aesthetic Medicine: URO-UEMXD and Derma Shine Duo RF Unveiled at WHX Dubai 2026

HealthDiscover the Future of Aesthetic Medicine: URO-UEMXD and Derma Shine Duo RF Unveiled at WHX Dubai 2026
Buyers participating in WHX Dubai 2026 are touring the Huons Meditech exhibition booth (Provided by Huons Meditech) / News1
Buyers participating in WHX Dubai 2026 are touring the Huons Meditech exhibition booth (Provided by Huons Meditech) / News1

Huons Meditech announced on Thursday its participation in WHX Dubai 2026, the Middle East’s premier healthcare exhibition, which kicked off on Monday in Dubai, United Arab Emirates (UAE).

WHX Dubai is a global healthcare showcase that draws a diverse crowd of medical device companies, buyers, and healthcare experts from the Middle East, Africa, Europe, and Asia.

At the exhibition, Huons Meditech highlighted its flagship products in urology, aesthetics, and infection control. The company reported significant interest in its URO-UEMXD extracorporeal shock wave lithotripter, which features an innovative in-line design combining a shock wave head with ultrasound technology. This device is praised for enhancing procedural efficiency by allowing more intuitive and precise lesion detection and stone fragmentation.

In the aesthetics realm, the newly unveiled Dermashine Duo RF captured attendees’ attention. This cutting-edge device merges precise drug injection capabilities with low-power radiofrequency (RF) technology, offering a dual approach to drug delivery and skin rejuvenation in one system.

Huons Meditech also showcased the Dermashine Pro, a precision skin drug injector, alongside the new Dermashine Duo RF. The company noted strong buyer interest in their DR-02 endoscope sterilizer, which offers an advanced solution for infection prevention and efficient equipment management in healthcare settings.

Chief Executive Officer (CEO) Ha Chang-woo of Huons Meditech remarked tha the enthusiastic response to our products at WHX Dubai 2026 underscores the high regard for Huons Meditech’s technological prowess. It is committed to aggressive international marketing efforts to establish themselves as leaders in the global medical device market.

Looking ahead, Huons Meditech is set to exhibit at Dubai Derma 2026, the Middle East’s largest beauty expo, from March 31 to April 2. The company plans to showcase its Dermashine Pro and Dermashine Duo RF, aiming to boost its global profile in aesthetics and further penetrate the Middle Eastern market.

Check Out Our Content

Check Out Other Tags:

Most Popular Articles